Table 3 |
||||||
|
Risk allele frequencies in Central and Southern European controls and relationship with the North/South score |
||||||
|
RAF (%) |
RAF vs. N/S score |
|||||
|
|
||||||
|
SNP (locus) |
Central European |
Southern European |
χ2 P value |
rxy |
Slope |
P value |
|
|
||||||
|
rs3131379 (MSH5) |
14.9 |
4.6 |
4.9 × 10-26 |
0.92 |
4.15 |
2.0 × 10-6 |
|
rs2187668 (HLA-DQA1) |
15.7 |
8.7 |
1.9 × 10-9 |
0.88 |
4.93 |
4.0 × 10-5 |
|
rs2476601 (PTPN22) |
11.8 |
6.1 |
1.5 × 10-8 |
0.74 |
4.21 |
2.7 × 10-3 |
|
rs13277113 (C8orf13-BLK) |
31.0 |
23.2 |
2.2 × 10-6 |
0.20 |
0.95 |
NS |
|
rs6445975 (PXK) |
29.0 |
22.6 |
7.5 × 10-5 |
0.66 |
2.67 |
0.01 |
|
rs1143679 (ITGAM) |
11.9 |
16.7 |
4.9 × 10-4 |
-0.59 |
-4.79 |
0.03 |
|
rs2205960 (TNFSF4) |
25.2 |
20.7 |
4.9 × 10-3 |
0.15 |
1.08 |
NS |
|
rs1801274 (FCGR2A) |
44.5 |
48.6 |
0.03 |
-0.40 |
-1.25 |
NS |
|
rs4963128 (KIAA1542) |
69.1 |
65.3 |
0.03 |
0.58 |
2.83 |
0.03 |
|
rs10488631 (IRF5) |
11.6 |
9.3 |
0.046 |
0.46 |
3.64 |
0.10 |
|
rs17435 (MECP2)a |
20.9 |
22.8 |
NS |
-0.57 |
-2.84 |
0.03 |
|
rs573775 (ATG5) |
28.2 |
26.3 |
NS |
0.51 |
4.10 |
0.06 |
|
rs7574865 (STAT4) |
23.3 |
23.8 |
NS |
-0.51 |
-4.63 |
0.06 |
|
rs6920220 (TNFAIP3) |
19.3 |
17.8 |
NS |
0.49 |
2.74 |
0.07 |
|
rs10798269 (1q25.1) |
66.2 |
69.0 |
NS |
-0.17 |
-1.16 |
NS |
|
rs5754217 (UBE2L3) |
22.8 |
20.8 |
NS |
0.16 |
1.28 |
NS |
|
rs2304256 (TYK2) |
73.1 |
71.0 |
NS |
0.06 |
0.23 |
NS |
|
rs2230926 (TNFAIP3) |
3.5 |
4.3 |
NS |
-0.21 |
-3.42 |
NS |
|
rs729302 (IRF5) |
67.8 |
69.0 |
NS |
-0.00 |
-0.03 |
NS |
|
rs17266594 (BANK1) |
71.2 |
70.9 |
NS |
0.32 |
1.99 |
NS |
|
|
||||||
|
Comparison of the risk allele frequencies (RAFs) between Central and Southern European controls, and linear regression of RAFs to the North/South score (N/S score) of population differentiation (from Table 1). NS, not significant. aAnalysis performed only in women because the locus is in the X chromosome. |
||||||
|
Alonso-Perez et al. Arthritis Research & Therapy 2012 14:R94 doi:10.1186/ar3818 |
||||||